Browning West and Glenn Chamandy Comment on Gildan Activewear’s Defensive and Reactionary Board Refreshment
- Browning West and Glenn Chamandy highlight Gildan Activewear's Board failures and defensive maneuvers.
- The Board's failure to reinstate Glenn as CEO despite shareholder demands is criticized.
- The newly appointed directors are considered less qualified than Browning West's candidates.
- Browning West aims to deliver a stock price of over $60 USD by 2025 and $100 USD within five years.
- The Board's excessive spending on entrenchment tactics is questioned.
- Glenn Chamandy seeks support from Browning West's slate for the best Board composition.
- Browning West is urging shareholders to vote for their highly qualified director candidates at the upcoming Annual Meeting of Shareholders on May 28, 2024.
- The Board's reluctance to reinstate Glenn as CEO despite shareholder demands could lead to continued unrest.
- The reactive sale process collapse could impact the company negatively in the long term.
- The ongoing board disputes and entrenchment tactics may create uncertainty among investors.
- The potential disruption caused by the Board's actions could affect the company's performance and shareholder value.
Gratified That Board Leadership, Including the Chairman and Every Committee Chair, Has Seemingly Acknowledged Their Many Failures by Resigning En Masse
Question Why the Board Has Gone to Such Lengths to Allow Vince Tyra to Remain CEO Despite His Track Record of Value Destruction and Amid Unprecedented Shareholder Calls to Reinstate Glenn Chamandy
Remind Shareholders That Electing the Full Browning West Slate is the Only Clear Path to Reinstating Glenn Chamandy as CEO to Generate Outstanding Shareholder Returns
Usman S. Nabi and Peter M. Lee of Browning West commented:
“The Board’s list of failures grows by the week: beginning with its botched succession process, followed by numerous diligence failures, a reactive and misguided sale process, and now a desperate and defensive Board refreshment. The most glaring omission in the Board’s latest maneuver is its failure to reinstate
Contrary to the Board’s false and misleading statements, support for
Glenn Chamandy, Gildan’s co-founder and former CEO, commented:
“When I return to Gildan as CEO, I want to be supported by the highest quality Board with relevant experience. I have spent time with members of the Browning West slate and believe they possess necessary track records of value creation, expertise in successful succession planning and corporate governance, and relevant operational, industry, and ESG experience. In addition, it is critical that I am supported by a Chairman who has a strong record as an operating CEO and Chair, which Mike Kneeland clearly possesses, and that there is an owners’ mindset in the boardroom, which Peter Lee of Browning West clearly possesses. The Browning West slate represents the best Board for all Gildan stakeholders.”
As a reminder, Browning West is seeking to elect eight highly qualified and independent director candidates to Gildan’s Board at the Annual Meeting of Shareholders on May 28, 2024. Browning West’s director candidates possess strong track records of value creation, expertise in successful succession planning, relevant industry and governance experience, as well as proven management and board service pedigrees in
Shareholders are encouraged to visit www.SuperchargeGildan.com to download a copy of the slate’s operating plan, learn how to vote for Browning West’s slate of highly qualified director candidates, and sign up for important campaign updates. Visit SEDAR+ (www.sedarplus.ca) to review a copy of Browning West’s information circular and other relevant materials.
Disclaimer for Forward-Looking Information
Certain information in this news release may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking statements and information generally can be identified by the use of forward-looking terminology such as “outlook,” “objective,” “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “plans,” “continue,” or similar expressions suggesting future outcomes or events. Forward-looking information in this news release may include, but is not limited to, statements of Browning West regarding (i) how Browning West intends to exercise its legal rights as a shareholder of the Company, and (ii) its plans to make changes at the Board and management of the Company.
Although Browning West believes that the expectations reflected in any such forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including, without limitation, the risks that (i) the Company may use tactics to thwart the rights of Browning West as a shareholder and (ii) the actions being proposed and the changes being demanded by Browning West, may not take place for any reason whatsoever. Except as required by law, Browning West does not intend to update these forward-looking statements.
Advisors
Olshan Frome Wolosky LLP is serving as legal counsel, Goodmans LLP is serving as Canadian legal counsel, and IMK is serving as
About Browning West, LP
Browning West is an independent investment partnership based in
Browning West seeks to identify and invest in a limited number of high-quality businesses and to hold these investments for multiple years. Backed by a select group of leading foundations, family offices, and university endowments, Browning West’s unique capital base allows it to focus on long-term value creation at its portfolio companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240422774793/en/
Browning West
info@browningwest.com
310-984-7600
Longacre Square Partners
Charlotte Kiaie / Scott Deveau, 646-386-0091
browningwest@longacresquare.com
Pelican PR
Lyla Radmanovich / Mélanie Tardif, 514-845-8763
media@rppelican.ca
Carson Proxy
Christine Carson, 416-804-0825
christine@carsonproxy.com
Source: Browning West, LP
FAQ
Why are Browning West and Glenn Chamandy critical of Gildan Activewear's Board refreshment?
What is the key demand from shareholders regarding Glenn Chamandy's reinstatement?
What is Browning West's plan regarding the new slate of directors for Gildan's Board?
What stock price targets does Browning West aim to achieve through its value creation plan?